Vanda Pharmaceuticals
VNDA
#8376
Rank
NZ$0.54 B
Marketcap
NZ$8.94
Share price
-2.76%
Change (1 day)
12.25%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): NZ-$6.96

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$6.85. In 2025 the company made an earnings per share (EPS) of NZ-$6.31 a decrease over its 2024 EPS that were of NZ-$0.54.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.9610.4%
2025NZ-$6.311065.63%
2024NZ-$0.54-710.9%
2023NZ$0.08856-56.35%
2022NZ$0.20-80%
2021NZ$1.01
2019NZ$3.67334%
2018NZ$0.85-247.06%
2017NZ-$0.57-19.05%
2016NZ-$0.71-55.32%
2015NZ-$1.59-347.37%
2014NZ$0.64-156.72%
2013NZ-$1.13-31.63%
2012NZ-$1.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.77-315.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.87-273.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.21-132.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$47.72-796.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.04-188.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.02-187.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ-$7.42 8.40%๐Ÿ‡บ๐Ÿ‡ธ USA